BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 14724589)

  • 1. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients.
    Petrovics G; Zhang W; Makarem M; Street JP; Connelly R; Sun L; Sesterhenn IA; Srikantan V; Moul JW; Srivastava S
    Oncogene; 2004 Jan; 23(2):605-11. PubMed ID: 14724589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.
    Srikantan V; Zou Z; Petrovics G; Xu L; Augustus M; Davis L; Livezey JR; Connell T; Sesterhenn IA; Yoshino K; Buzard GS; Mostofi FK; McLeod DG; Moul JW; Srivastava S
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12216-21. PubMed ID: 11050243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.
    Xu LL; Shi Y; Petrovics G; Sun C; Makarem M; Zhang W; Sesterhenn IA; McLeod DG; Sun L; Moul JW; Srivastava S
    Cancer Res; 2003 Aug; 63(15):4299-304. PubMed ID: 12907594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.
    Fu X; Ravindranath L; Tran N; Petrovics G; Srivastava S
    DNA Cell Biol; 2006 Mar; 25(3):135-41. PubMed ID: 16569192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
    Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
    Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 17 is over-expressed in human prostate cancer.
    Heer R; Douglas D; Mathers ME; Robson CN; Leung HY
    J Pathol; 2004 Dec; 204(5):578-86. PubMed ID: 15538740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PC-1/PrLZ contributes to malignant progression in prostate cancer.
    Zhang H; Wang J; Pang B; Liang RX; Li S; Huang PT; Wang R; Chung LW; Zhau HE; Huang C; Zhou JG
    Cancer Res; 2007 Sep; 67(18):8906-13. PubMed ID: 17875733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer.
    Korkmaz CG; Korkmaz KS; Kurys P; Elbi C; Wang L; Klokk TI; Hammarstrom C; Troen G; Svindland A; Hager GL; Saatcioglu F
    Oncogene; 2005 Jul; 24(31):4934-45. PubMed ID: 15897894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrLZ expression is associated with the progression of prostate cancer LNCaP cells.
    Li L; Zhang D; Zhang L; Zhu G; Sun Y; Wu K; Wang X; He D
    Mol Carcinog; 2009 May; 48(5):432-40. PubMed ID: 18800346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrLZ is expressed in normal prostate development and in human prostate cancer progression.
    Wang R; Xu J; Mabjeesh N; Zhu G; Zhou J; Amin M; He D; Marshall FF; Zhau HE; Chung LW
    Clin Cancer Res; 2007 Oct; 13(20):6040-8. PubMed ID: 17947466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
    Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
    Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
    Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
    Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
    Agoulnik IU; Vaid A; Bingman WE; Erdeme H; Frolov A; Smith CL; Ayala G; Ittmann MM; Weigel NL
    Cancer Res; 2005 Sep; 65(17):7959-67. PubMed ID: 16140968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the androgen receptor pathway during progression of prostate cancer.
    Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
    Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
    You Z; Shi XB; DuRaine G; Haudenschild D; Tepper CG; Lo SH; Gandour-Edwards R; de Vere White RW; Reddi AH
    Cancer Res; 2006 Jan; 66(1):175-83. PubMed ID: 16397230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
    Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME
    Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.